Expanding the human proteome with microproteins and peptideins
| dc.contributor.author | Deutsch, Eric W. | |
| dc.contributor.author | Kok, Leron W. | |
| dc.contributor.author | Mudge, Jonathan M. | |
| dc.contributor.author | Valls, Cristian F. | |
| dc.contributor.author | Jungreis, Irwin | |
| dc.contributor.author | Ruiz-Orera, Jorge | |
| dc.contributor.author | Sun, Zhi | |
| dc.contributor.author | Kusebauch, Ulrike | |
| dc.contributor.author | Fierro-Monti, Ivo | |
| dc.contributor.author | Abelin, Jennifer G. | |
| dc.contributor.author | Alba, M. Mar | |
| dc.contributor.author | Aspden, Julie L. | |
| dc.contributor.author | Bandyopadhyay, Sreejan | |
| dc.contributor.author | Banerjee, Kaushik | |
| dc.contributor.author | Baranov, Pavel V. | |
| dc.contributor.author | Bazzini, Ariel A. | |
| dc.contributor.author | Bourassa, Francis | |
| dc.contributor.author | Bruford, Elspeth A. | |
| dc.contributor.author | Calviello, Lorenzo | |
| dc.contributor.author | Carr, Steven A. | |
| dc.contributor.author | Carvunis, Anne Ruxandra | |
| dc.contributor.author | Chothani, Sonia | |
| dc.contributor.author | Clauwaert, Jim | |
| dc.contributor.author | Dean, Kellie | |
| dc.contributor.author | Faridi, Pouya | |
| dc.contributor.author | Frankish, Adam | |
| dc.contributor.author | Goodale, Amy | |
| dc.contributor.author | Green, Thomas | |
| dc.contributor.author | Hubner, Norbert | |
| dc.contributor.author | Ingolia, Nicholas T. | |
| dc.contributor.author | Kellis, Manolis | |
| dc.contributor.author | Magrane, Michele | |
| dc.contributor.author | Martin, Maria Jesus | |
| dc.contributor.author | Martinez, Thomas F. | |
| dc.contributor.author | Menschaert, Gerben | |
| dc.contributor.author | Ohler, Uwe | |
| dc.contributor.author | Orchard, Sandra | |
| dc.contributor.author | Potter, Alisa | |
| dc.contributor.author | Rackham, Owen J.L. | |
| dc.contributor.author | Rees, Matthew G. | |
| dc.contributor.author | Root, David E. | |
| dc.contributor.author | Roth, Jennifer A. | |
| dc.contributor.author | Roucou, Xavier | |
| dc.contributor.author | Sialana, Fernando J. | |
| dc.contributor.author | Slavoff, Sarah A. | |
| dc.contributor.author | Świrski, Michał I. | |
| dc.contributor.author | Tierney, Jack A.S. | |
| dc.contributor.author | Trifiro, Félix Antoine | |
| dc.contributor.author | Valen, Eivind | |
| dc.contributor.author | Vasylieva, Valeriia | |
| dc.contributor.author | Wacholder, Aaron | |
| dc.contributor.author | Wang, Shengbo | |
| dc.contributor.author | Wang, Li | |
| dc.contributor.author | Weissman, Jonathan S. | |
| dc.contributor.author | Wu, Wei | |
| dc.contributor.author | Xie, Zhi | |
| dc.contributor.author | Choudhary, Jyoti S. | |
| dc.contributor.author | Bassani-Sternberg, Michal | |
| dc.contributor.author | Vizcaíno, Juan Antonio | |
| dc.contributor.author | Ternette, Nicola | |
| dc.contributor.author | Brunet, Marie A. | |
| dc.contributor.author | Moritz, Robert L. | |
| dc.contributor.author | Prensner, John R. | |
| dc.contributor.author | van Heesch, Sebastiaan | |
| dc.contributor.funder | Université de Sherbrooke, UDS | |
| dc.contributor.funder | Dutch National Growth Fund | |
| dc.contributor.funder | Tough2gether Foundation | |
| dc.contributor.funder | Office of the Director | |
| dc.contributor.funder | Broad Institute, BI | |
| dc.contributor.funder | DMG Research Funding Alliance | |
| dc.contributor.funder | Rogel Cancer Center, University of Michigan | |
| dc.contributor.funder | Chad Carr Pediatric Brain Tumor Center | |
| dc.contributor.funder | Fondation KickCancer | |
| dc.contributor.funder | DIPG | |
| dc.contributor.funder | National Institute of General Medical Sciences, NIGMS | |
| dc.contributor.funder | Villa Joep | |
| dc.contributor.funder | Division of Program Coordination, Planning, and Strategic Initiatives, DPCPSI | |
| dc.contributor.funder | CRIDO | |
| dc.contributor.funder | Imagine for Margo | |
| dc.contributor.funder | Federazione Italiana Associazioni Genitori e Guariti Oncoematologia Pediatrica | |
| dc.contributor.funder | EU Horizon 2020 Pathfinder Program | |
| dc.contributor.funder | Hyundai Hope on Wheels Foundation | |
| dc.contributor.funder | Stichting Reggeborgh and Villa Joep | |
| dc.contributor.funder | Fonds Cancers (FOCA, Belgium) | |
| dc.contributor.funder | Horizon 2020 Framework Programme | |
| dc.contributor.funder | Oncode Institute | |
| dc.contributor.funder | CRIDO Roots of the Future scholarship and the Poland National Science Centre | |
| dc.contributor.funder | Stichting Reggeborgh | |
| dc.contributor.funder | Fight Kids Cancer Funding Programme | |
| dc.contributor.funder | Centro Singular de Investigación de Galicia, CINBIO | |
| dc.contributor.funder | National Institute of Allergy and Infectious Diseases, NIAID | |
| dc.contributor.funder | Yuvaan Tiwari Foundation | |
| dc.contributor.funder | Victorian Cancer Agency, VCA | |
| dc.contributor.funder | KWF Kankerbestrijding, KWF | |
| dc.contributor.funder | National Heart, Lung, and Blood Institute, NHLBI | |
| dc.contributor.funder | Fondatioun Kriibskrank Kanner | |
| dc.contributor.funder | Morgan Adams Foundation | |
| dc.contributor.funder | Hope Foundation | |
| dc.contributor.funder | Fonds Cancers | |
| dc.contributor.funder | National Eye Institute, NEI | |
| dc.contributor.funder | Stichting Kinderen Kankervrij | |
| dc.contributor.funder | Fundacja na rzecz Nauki Polskiej, FNP | |
| dc.contributor.funder | CRIS Cancer Foundation | |
| dc.contributor.funder | Center for Cancer Research, CCR | |
| dc.contributor.funder | Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, AMRF | |
| dc.contributor.funder | National Institute on Aging, NIA | |
| dc.contributor.funder | Ben and Catherine Ivy Foundation, BCIF | |
| dc.contributor.funder | RTI | |
| dc.contributor.funder | V Foundation for Cancer Research, VFCR, V2024-013 | |
| dc.contributor.funder | Narodowe Centrum Nauki, NCN, UMO-2021/41/B/NZ2/03036 | |
| dc.contributor.funder | National Science Foundation, NSF, MRI-1920268-DBI-1933311 | |
| dc.contributor.funder | Andrew McDonough B+ Foundation, AMBF, 1548557 | |
| dc.contributor.funder | Oncode Accelerator, NGFOP2201 | |
| dc.contributor.funder | H2020 Marie Skłodowska-Curie Actions, MSCA, 945405 | |
| dc.contributor.funder | Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO, VI.Vidi.223.022 | |
| dc.contributor.funder | Damon Runyon Cancer Research Foundation, DRCRF, CI-127-24 | |
| dc.contributor.funder | National Institute of Diabetes and Digestive and Kidney Diseases, NIAMDD, U24HG007822 | |
| dc.contributor.funder | Biotechnology and Biological Sciences Research Council, AFRC, BB/S01781X/1-BB/Y513829/1 | |
| dc.contributor.funder | Lindonlight Collective, GR-24-008-GR-24-012 | |
| dc.contributor.funder | Santé, FRQS, 354090-352705-367740 | |
| dc.contributor.funder | Cannonball Kids' cancer Foundation, CKc, 45 | |
| dc.contributor.funder | National Human Genome Research Institute, NHGRI, U24HG007234-U24HG00334 | |
| dc.contributor.funder | Lung Cancer Research Foundation, LCRF, 1491799 | |
| dc.contributor.funder | National Institutes of Health, USNIH, S10 OD026936-R35GM157126-P01CA206978-R01 GM087221-R24 GM148372 | |
| dc.contributor.funder | Deutsche Forschungsgemeinschaft, DFG, CRC 1470-CRC 1700 | |
| dc.contributor.funder | Wellcome Trust, WT, 223745/Z/21/Z | |
| dc.contributor.funder | National Cancer Institute, NCI, K08-CA263552-01A1-U24CA270823-U01CA271402 | |
| dc.contributor.funder | National Health and Medical Research Council, NHMRC, U24HG007234-222155/Z/20/Z | |
| dc.contributor.funder | Nature et technologies, FRQNT, 354964 | |
| dc.contributor.funder | Research Ireland, 20/FFP-A/8929-R35GM157126-U01CA271402-P01CA206978-U24CA270823 | |
| dc.contributor.funder | Natural Sciences and Engineering Research Council of Canada, CRSNG, RTI-2024-00556-RGPIN-2023-05203 | |
| dc.contributor.funder | American Brain Tumor Association, ABTA, DG2500077 | |
| dc.contributor.funder | Engineering and Physical Sciences Research Council, SRC, EP/Y035984/1 | |
| dc.contributor.funder | European Molecular Biology Laboratory, EMBL, U24HG00334 | |
| dc.contributor.funder | European Research Council, ERC, AdG788970 | |
| dc.date.accessioned | 2026-06-30T13:50:08Z | |
| dc.date.available | 2026-06-30T13:50:08Z | |
| dc.date.issued | 2026-06-18 | |
| dc.description.abstract | A major scientific drive is to characterize the protein-coding genome, which is a primary basis for studying human health. But the fundamental question remains of what has been missed in previous analyses. Over the past decade, the translation of non-canonical open reading frames (ncORFs) has been observed across human cell types and disease states1, 2–3, with major implications for biomedical science. However, a key gap in knowledge has been which ncORFs produce small microproteins or alternative protein molecules that contribute to the human proteome. Here we report the collaborative efforts of the TransCODE Consortium4 to produce a consensus landscape of protein-level evidence for ncORFs. We show that about 25% of a set of 7,264 ncORFs gives rise to detectable peptides in a large-scale analysis of 95,520 proteomics experiments. We develop an annotation framework for ncORF-encoded microproteins as human proteins and codify the new conceptual model of ‘peptideins’ as microproteins that have indeterminate potential as functional proteins. To probe the biological implications of peptideins, we create an evolutionary analysis approach, termed ORF relative branch length (ORBL), and determine that evolutionary constraint is common and associates with observation of ncORF-derived peptides. We then characterize a pan-essential cellular phenotype for one peptidein from the OLMALINC long non-coding RNA. Overall, we generate public research tools supported by GENCODE and PeptideAtlas and advance biomedical discovery for understudied components of the human proteome. | en |
| dc.description.sponsorship | We acknowledge the authors of many excellent research publications in this field. This work was funded in part by the National Institutes of Health grants R01 GM087221 (E.W.D., R.L.M.), R24 GM148372 (E.W.D.), S10 OD026936 (R.L.M.) and by the National Science Foundation grants DBI-1933311 (E.W.D.) and MRI-1920268 (R.L.M.). J.R.P. acknowledges funding from the National Institutes of Health/National Cancer Institute (K08-CA263552-01A1) | |
| dc.description.sponsorship | the V Foundation for Cancer Research (V2024-013) | |
| dc.description.sponsorship | Tough2gether Foundation | |
| dc.description.sponsorship | Hyundai Hope on Wheels Foundation | |
| dc.description.sponsorship | the Yuvaan Tiwari Foundation | |
| dc.description.sponsorship | DIPG/DMG Research Funding Alliance | |
| dc.description.sponsorship | Book for Hope Foundation | |
| dc.description.sponsorship | CureSearch for Cancer Research | |
| dc.description.sponsorship | Morgan Adams Foundation | |
| dc.description.sponsorship | and the Andrew McDonough B+ Foundation (1548557) | |
| dc.description.sponsorship | the Lindonlight Collective (GR-24-008 and GR-24-012) | |
| dc.description.sponsorship | the Lung Cancer Research Foundation (1491799) | |
| dc.description.sponsorship | the American Brain Tumor Association (DG2500077) | |
| dc.description.sponsorship | the Cannonball Kids Cancer Foundation (45) | |
| dc.description.sponsorship | the Chad Carr Pediatric Brain Tumor Center | |
| dc.description.sponsorship | and the University of Michigan Rogel Cancer Center. J.R.P. is the Ben and Catherine Ivy Foundation Clinical Investigator of the Damon Runyon Cancer Research Foundation (CI-127-24). S.v.H. acknowledges funding from Fonds Cancers (FOCA, Belgium), Stichting Reggeborgh and Villa Joep. This project was partially supported by the Fight Kids Cancer Funding Programme, supported by Imagine for Margo, Fondation KickCancer, Fondatioun Kriibskrank Kanner, Federazione Italiana Associazioni Genitori e Guariti Oncoematologia Pediatrica, Cris Cancer Foundation and Stichting Kinderen Kankervrij (KiKa). This publication is part of the project “Evolutionarily young microproteins in childhood brain cancer” with project number VI.Vidi.223.022 of the research programme NWO talent programme Vidi, which is partly financed by the Dutch Research Council (NWO), awarded to S.v.H. Research reported in this publication was supported by Oncode Accelerator, a Dutch National Growth Fund project under grant number NGFOP2201, awarded to S.v.H. This work is co-financed by Oncode Institute, which is partly funded by the Dutch Cancer Society. J.A.V. acknowledges funding from the Wellcome Trust (223745/Z/21/Z), BBSRC (BB/Y513829/1, BB/S01781X/1) and EPSRC (EP/Y035984/1). M.M., M.J.M. and S.O. acknowledge funding from the National Human Genome Research Institute (NHGRI), Office of Director (OD/DPCPSI/ODSS), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Aging (NIA), National Institute of General Medical Sciences (NIGMS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Eye Institute (NEI), National Cancer Institute (NCI), National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health under Award Number U24HG007822. I.F.-M. acknowledges funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 945405. P.V.B. acknowledges funding from Taighde Éireann—Research Ireland (20/FFP-A/8929). T.F.M. acknowledges financial support from NIH grant R35GM157126. J.G.A and S.A.C. are supported in part by grants P01CA206978 from the NIH, and grants U24CA270823 and U01CA271402 from the NCI Clinical Proteomic Tumor Analysis Consortium program, as well as a grant from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to S.A.C. J.G.A. acknowledges funding from the Broad Institute’s Merkin Institute Fellowship. N.H. was supported by ERC Advanced Grant (EU Horizon 2020, AdG788970), Deutsche Forschungsgemeinschaft (DFG | |
| dc.description.sponsorship | CRC 1470 and CRC 1700) and the EU Horizon 2020 Pathfinder Program. P.F. was supported by a Victorian Cancer Agency Mid-Career Fellowship and the National Health and Medical Research Council of Australia (NHMRC). J.M.M., A.F., J.R.P., and I.J. are supported by the National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH) under award number U24HG007234. J.M.M. and A.F. are supported by the Wellcome Trust (grant number 222155/Z/20/Z). J.M.M., A.F., J.A.S.T., J.A.V., M.M., M.J.M. and S.O are supported by EMBL core funding. E.A.B. is funded by the NHGRI grant U24HG00334. M.A.B. acknowledges funding from the NSERC (Discovery grant RGPIN-2023-05203 and RTI grant RTI-2024-00556). M.A.B. is supported by a FRQS Junior 2 award (367740) and a research chair from the Centre de Recherche Medicale de l’Universite de Sherbrooke (CRMUS). F.-A.T. and F.B. are supported by FRQS scholarships (354090 and 352705, respectively). V.V. is supported by a FRQNT scholarship (354964). J.S.C. and S.B. acknowledge funding from the Wellcome Trust (223745/Z/21/Z) and Biomedical Research Centre. M.I.Ś. was supported by Foundation for Polish Science START scholarship, CRIDO Roots of the Future scholarship and the Poland National Science Centre (UMO-2021/41/B/NZ2/03036). We thank J. Causon, K. Tran and C. Feasley for providing access and for data collection on the Sciex ZenoTOF 8600 MS system. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Ensembl is a registered trademark of EMBL. We acknowledge the authors of many excellent research publications in this field. This work was funded in part by the National Institutes of Health grants R01 GM087221 (E.W.D., R.L.M.), R24 GM148372 (E.W.D.), S10 OD026936 (R.L.M.) and by the National Science Foundation grants DBI-1933311 (E.W.D.) and MRI-1920268 (R.L.M.). J.R.P. acknowledges funding from the National Institutes of Health/National Cancer Institute (K08-CA263552-01A1) | |
| dc.description.sponsorship | the V Foundation for Cancer Research (V2024-013) | |
| dc.description.sponsorship | Tough2gether Foundation | |
| dc.description.sponsorship | Hyundai Hope on Wheels Foundation | |
| dc.description.sponsorship | the Yuvaan Tiwari Foundation | |
| dc.description.sponsorship | DIPG/DMG Research Funding Alliance | |
| dc.description.sponsorship | Book for Hope Foundation | |
| dc.description.sponsorship | CureSearch for Cancer Research | |
| dc.description.sponsorship | Morgan Adams Foundation | |
| dc.description.sponsorship | and the Andrew McDonough B+ Foundation (1548557) | |
| dc.description.sponsorship | the Lindonlight Collective (GR-24-008 and GR-24-012) | |
| dc.description.sponsorship | the Lung Cancer Research Foundation (1491799) | |
| dc.description.sponsorship | the American Brain Tumor Association (DG2500077) | |
| dc.description.sponsorship | the Cannonball Kids Cancer Foundation (45) | |
| dc.description.sponsorship | the Chad Carr Pediatric Brain Tumor Center | |
| dc.description.sponsorship | and the University of Michigan Rogel Cancer Center. J.R.P. is the Ben and Catherine Ivy Foundation Clinical Investigator of the Damon Runyon Cancer Research Foundation (CI-127-24). S.v.H. acknowledges funding from Fonds Cancers (FOCA, Belgium), Stichting Reggeborgh and Villa Joep. This project was partially supported by the Fight Kids Cancer Funding Programme, supported by Imagine for Margo, Fondation KickCancer, Fondatioun Kriibskrank Kanner, Federazione Italiana Associazioni Genitori e Guariti Oncoematologia Pediatrica, Cris Cancer Foundation and Stichting Kinderen Kankervrij (KiKa). This publication is part of the project “Evolutionarily young microproteins in childhood brain cancer” with project number VI.Vidi.223.022 of the research programme NWO talent programme Vidi, which is partly financed by the Dutch Research Council (NWO), awarded to S.v.H. Research reported in this publication was supported by Oncode Accelerator, a Dutch National Growth Fund project under grant number NGFOP2201, awarded to S.v.H. This work is co-financed by Oncode Institute, which is partly funded by the Dutch Cancer Society. J.A.V. acknowledges funding from the Wellcome Trust (223745/Z/21/Z), BBSRC (BB/Y513829/1, BB/S01781X/1) and EPSRC (EP/Y035984/1). M.M., M.J.M. and S.O. acknowledge funding from the National Human Genome Research Institute (NHGRI), Office of Director (OD/DPCPSI/ODSS), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Aging (NIA), National Institute of General Medical Sciences (NIGMS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Eye Institute (NEI), National Cancer Institute (NCI), National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health under Award Number U24HG007822. I.F.-M. acknowledges funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 945405. P.V.B. acknowledges funding from Taighde Éireann—Research Ireland (20/FFP-A/8929). T.F.M. acknowledges financial support from NIH grant R35GM157126. J.G.A and S.A.C. are supported in part by grants P01CA206978 from the NIH, and grants U24CA270823 and U01CA271402 from the NCI Clinical Proteomic Tumor Analysis Consortium program, as well as a grant from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to S.A.C. J.G.A. acknowledges funding from the Broad Institute’s Merkin Institute Fellowship. N.H. was supported by ERC Advanced Grant (EU Horizon 2020, AdG788970), Deutsche Forschungsgemeinschaft (DFG | |
| dc.description.sponsorship | CRC 1470 and CRC 1700) and the EU Horizon 2020 Pathfinder Program. P.F. was supported by a Victorian Cancer Agency Mid-Career Fellowship and the National Health and Medical Research Council of Australia (NHMRC). J.M.M., A.F., J.R.P., and I.J. are supported by the National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH) under award number U24HG007234. J.M.M. and A.F. are supported by the Wellcome Trust (grant number 222155/Z/20/Z). J.M.M., A.F., J.A.S.T., J.A.V., M.M., M.J.M. and S.O are supported by EMBL core funding. E.A.B. is funded by the NHGRI grant U24HG00334. M.A.B. acknowledges funding from the NSERC (Discovery grant RGPIN-2023-05203 and RTI grant RTI-2024-00556). M.A.B. is supported by a FRQS Junior 2 award (367740) and a research chair from the Centre de Recherche Medicale de l’Universite de Sherbrooke (CRMUS). F.-A.T. and F.B. are supported by FRQS scholarships (354090 and 352705, respectively). V.V. is supported by a FRQNT scholarship (354964). J.S.C. and S.B. acknowledge funding from the Wellcome Trust (223745/Z/21/Z) and Biomedical Research Centre. M.I.Ś. was supported by Foundation for Polish Science START scholarship, CRIDO Roots of the Future scholarship and the Poland National Science Centre (UMO-2021/41/B/NZ2/03036). We thank J. Causon, K. Tran and C. Feasley for providing access and for data collection on the Sciex ZenoTOF 8600 MS system. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Ensembl is a registered trademark of EMBL. | |
| dc.description.version | Published Version | |
| dc.format.extent | 13 | |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.authororcid | Deutsch, Eric W. | |
| dc.identifier.authororcid | Kok, Leron W. | |
| dc.identifier.authororcid | Mudge, Jonathan M. | |
| dc.identifier.authororcid | Valls, Cristian F. | |
| dc.identifier.authororcid | Jungreis, Irwin | |
| dc.identifier.authororcid | Ruiz-Orera, Jorge | |
| dc.identifier.authororcid | Sun, Zhi | |
| dc.identifier.authororcid | Kusebauch, Ulrike | |
| dc.identifier.authororcid | Fierro-Monti, Ivo | |
| dc.identifier.authororcid | Abelin, Jennifer G. | |
| dc.identifier.authororcid | Alba, M. Mar | |
| dc.identifier.authororcid | Aspden, Julie L. | |
| dc.identifier.authororcid | Bandyopadhyay, Sreejan | |
| dc.identifier.authororcid | Banerjee, Kaushik | |
| dc.identifier.authororcid | Baranov, Pavel V. | |
| dc.identifier.authororcid | Bazzini, Ariel A. | |
| dc.identifier.authororcid | Bourassa, Francis | |
| dc.identifier.authororcid | Bruford, Elspeth A. | |
| dc.identifier.authororcid | Calviello, Lorenzo | |
| dc.identifier.authororcid | Carr, Steven A. | |
| dc.identifier.authororcid | Carvunis, Anne Ruxandra | |
| dc.identifier.authororcid | Chothani, Sonia | |
| dc.identifier.authororcid | Clauwaert, Jim | |
| dc.identifier.authororcid | Dean, Kellie§0000-0002-3213-8181 | |
| dc.identifier.authororcid | Faridi, Pouya | |
| dc.identifier.authororcid | Frankish, Adam | |
| dc.identifier.authororcid | Goodale, Amy | |
| dc.identifier.authororcid | Green, Thomas | |
| dc.identifier.authororcid | Hubner, Norbert | |
| dc.identifier.authororcid | Ingolia, Nicholas T. | |
| dc.identifier.authororcid | Kellis, Manolis | |
| dc.identifier.authororcid | Magrane, Michele | |
| dc.identifier.authororcid | Martin, Maria Jesus | |
| dc.identifier.authororcid | Martinez, Thomas F. | |
| dc.identifier.authororcid | Menschaert, Gerben | |
| dc.identifier.authororcid | Ohler, Uwe | |
| dc.identifier.authororcid | Orchard, Sandra | |
| dc.identifier.authororcid | Potter, Alisa | |
| dc.identifier.authororcid | Rackham, Owen J.L. | |
| dc.identifier.authororcid | Rees, Matthew G. | |
| dc.identifier.authororcid | Root, David E. | |
| dc.identifier.authororcid | Roth, Jennifer A. | |
| dc.identifier.authororcid | Roucou, Xavier | |
| dc.identifier.authororcid | Sialana, Fernando J. | |
| dc.identifier.authororcid | Slavoff, Sarah A. | |
| dc.identifier.authororcid | Świrski, Michał I. | |
| dc.identifier.authororcid | Tierney, Jack A.S. | |
| dc.identifier.authororcid | Trifiro, Félix Antoine | |
| dc.identifier.authororcid | Valen, Eivind | |
| dc.identifier.authororcid | Vasylieva, Valeriia | |
| dc.identifier.authororcid | Wacholder, Aaron | |
| dc.identifier.authororcid | Wang, Shengbo | |
| dc.identifier.authororcid | Wang, Li | |
| dc.identifier.authororcid | Weissman, Jonathan S. | |
| dc.identifier.authororcid | Wu, Wei | |
| dc.identifier.authororcid | Xie, Zhi | |
| dc.identifier.authororcid | Choudhary, Jyoti S. | |
| dc.identifier.authororcid | Bassani-Sternberg, Michal | |
| dc.identifier.authororcid | Vizcaíno, Juan Antonio | |
| dc.identifier.authororcid | Ternette, Nicola | |
| dc.identifier.authororcid | Brunet, Marie A. | |
| dc.identifier.authororcid | Moritz, Robert L. | |
| dc.identifier.authororcid | Prensner, John R. | |
| dc.identifier.authororcid | van Heesch, Sebastiaan | |
| dc.identifier.citation | Deutsch, E W, Kok, L W, Mudge, J M, Valls, C F, Jungreis, I, Ruiz-Orera, J, Sun, Z, Kusebauch, U, Fierro-Monti, I, Abelin, J G, Alba, M M, Aspden, J L, Bandyopadhyay, S, Banerjee, K, Baranov, P V, Bazzini, A A, Bourassa, F, Bruford, E A, Calviello, L, Carr, S A, Carvunis, A R, Chothani, S, Clauwaert, J, Dean, K, Faridi, P, Frankish, A, Goodale, A, Green, T, Hubner, N, Ingolia, N T, Kellis, M, Magrane, M, Martin, M J, Martinez, T F, Menschaert, G, Ohler, U, Orchard, S, Potter, A, Rackham, O J L, Rees, M G, Root, D E, Roth, J A, Roucou, X, Sialana, F J, Slavoff, S A, Świrski, M I, Tierney, J A S, Trifiro, F A, Valen, E, Vasylieva, V, Wacholder, A, Wang, S, Wang, L, Weissman, J S, Wu, W, Xie, Z, Choudhary, J S, Bassani-Sternberg, M, Vizcaíno, J A, Ternette, N, Brunet, M A, Moritz, R L, Prensner, J R & van Heesch, S 2026, 'Expanding the human proteome with microproteins and peptideins', Nature, vol. 654, no. 8119, pp. 813-825. https://doi.org/10.1038/s41586-026-10459-x | |
| dc.identifier.doi | 10.1038/s41586-026-10459-x | |
| dc.identifier.endpage | 825 | |
| dc.identifier.issn | 0028-0836 | |
| dc.identifier.issued | 8119 | |
| dc.identifier.journaltitle | Nature | |
| dc.identifier.other | ORCID: /0000-0002-3213-8181/work/231477570 | |
| dc.identifier.startpage | 813 | |
| dc.identifier.uri | https://hdl.handle.net/10468/18982 | |
| dc.identifier.volume | 654 | |
| dc.language.iso | en | |
| dc.publisher | Nature Research | |
| dc.relation.uri | https://www.scopus.com/pages/publications/105038148448 | |
| dc.rights | © The Author(s) 2026. Open Access. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. | |
| dc.rights.accessrights | open access | |
| dc.rights.licensename | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.status | Peer reviewed | |
| dc.subject | Human proteome | |
| dc.subject | [BiochemistryCellBiology] | |
| dc.subject | Microproteins | |
| dc.subject | Peptideins | |
| dc.title | Expanding the human proteome with microproteins and peptideins | en |
| dc.type | Article (peer-reviewed) |
Files
Original bundle
1 - 1 of 1
